Bial - News and Events

News and Events

2012-04-13 18:34:02BIAL Foundation opens applications to the 10th edition of BIAL Scientific Research Bursaries
The BIAL Foundation has just opened applications to a new Bursary package in the fields of Psychophysiology and Parapsychology.
2012-03-26 13:19:28"Sleep and Dreams": latest findings in discussion on the 9th Symposium Behind and Beyond the Brain
"Sleep and Dreams": latest findings on the 9th Symposium Behind and Beyond the Brain
2012-02-24 15:34:42A Bial Foundation Fellow published a full paper in the prestigious journal “PAIN”
The Bial Foundation fellow Magne Flaten published the full paper “Variability in placebo analgesia and the role of fear of pain—an ERP study” in the prestigious journal "PAIN".
2012-02-16 16:03:14BIAL makes an investment of 40 million Euros to strengthen its international presence in the allergic immunotherapy area
BIAL invested 12 million Euros in a new plant in the Science and Technology Park of Biscay, in Bilbao, Spain, for the production and research of immunotherapy.
2012-01-26 16:04:15BIAL Foundation opens applications to the 15th edition of BIAL Award
BIAL Foundation has just opened applications to the 15th edition of BIAL Award, one of the most prestigious awards of scientific research in the area of health in Europe.
2011-08-30 19:05:23BIAL among European’s largest investors in R & D
BIAL among European’s largest investors in R & D
2011-05-07 16:03:25One of the most important awards in the area of Health in Europe
BIAL Merit Award in Medical Sciences: An innovative look at Alzheimer's disease
2011-04-15 11:57:19BIAL among the most reputatable companies
BIAL reached 17th place in RepTrak™ Pulse 2011 Portugal - "Portugal’s most reputable companies". The result (80.01) indicates an Excellent reputation of BIAL by the general public.
2011-04-15 10:23:42Antiepileptic drug launched in Greece and in the Republic of Ireland
The new antiepileptic drug from the BIAL Group has just been launched in Greece and in the Republic of Ireland after reaching reimbursement agreements. The launch in these markets comes under the license agreement and co-promotion signed between BIAL and the multinational Eisai, in February 2009, for marketing the drug in several European countries.
2011-02-10 15:25:45ZEBINIX, NOVEL ONCE-DAILY ANTI-EPILEPTIC TREATMENT, LAUNCHES IN SPAIN
Zebinix® (eslicarbazepine acetate), an add-on (adjunctive) therapy for adults with partial-onset seizures, with or without secondary generalisation (where the seizure spreads to both sides of the brain), has been launched today in Spain by Eisai and BIAL in a co-promotion.
2011-01-28 18:57:49Fourth generation at the head of the largest Portuguese pharmaceutical company
Luís Portela takes the position of Chairman. R&D and international expansion are the major projects for the next decade
2010-11-24 15:58:56BIAL is the company in the area of health that invests more in R&D in Portugal
BIAL Group ranks fourth, and first in the area of health, in the ranking of the 100 companies with more investment in research and development (R&D) in 2008 in Portugal.
2010-11-08 17:49:57Scottish Medicines Consortium (SMC) approves BIAL antiepileptic
Scottish Medicines Consortium (SMC) approves BIAL antiepileptic
2010-09-30 11:54:36BIAL chosen as best Portuguese company in Spain
BIAL was voted the best Portuguese company operating in Spain by the Câmara Hispano Portuguesa, which aims to spotlight the growth and consolidation of firms in the Iberian market.
2010-09-17 17:23:51Applications to the Bial Award are open until the end of October
The BIAL Award, one of the most prestigious awards of scientific research in the area of health in Europe, is accepting applications until the end of October.
2010-07-13 16:19:29BIAL buys Italian firm
BIAL buys Italian firm . Allergic immunotherapy business in growth.